Guidance

Tetanus: the green book, chapter 30

Tetanus immunisation information for public health professionals, including updates.

From:
UK Health Security Agency
PublishedPublished:
20 March 2013
Last updatedupdated:
314 JuneAugust 20252026 — See all updates

Documents

Tetanus: the green book, chapter 30

PDF, 287 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This chapter is being updated to include updated Immunoglobulin advice for treatment and PEP for tetanus. Please refer to the national guidance Tetanus: advice for health professionals - GOV.UK for updated advice in the interim.

This edition includes updates on:

  • epidemiology of tetanus
  • management of tetanus prone wounds
  • correct dose of immunoglobulin for prevention of tetanus
  • use of immunoglobulins for the treatment of clinical tetanus

Tetanus is an acute disease caused by the action of tetanus toxin, released following infection by the bacterium Clostridium tetani.

In November 2018 revised guidance for healthcare professionals on the use of immunoglobulins for the treatment of clinical tetanus and the management of tetanus prone wounds was issued.

Chapter 30 update patches.

Updates to this page

Published 20 March 2013
Last updated 314 JuneAugust 20252026 href="#full-history">+— show Show all updates

  2. Updated with the routine childhood schedule change of a new 18-month hexavalent dose.

Sign up for emails or print this page